Veraxa Biotech AG (VRXA)
NASDAQ: VRXA · Real-Time Price · USD
1.260
+0.170 (15.60%)
At close: Oct 9, 2026, 4:00 PM EDT
1.190
-0.070 (-5.56%)
After-hours: Oct 9, 2026, 7:40 PM EDT
Veraxa Biotech AG Market Cap
Veraxa Biotech AG has a market cap or net worth of $178.17 million as of October 9, 2026. It is the 21,658th most valuable company in the world and the 3,707th biggest in the United States. Its market cap has decreased by 46.14% in one year.
Market Cap
178.17M
Enterprise Value
177.58M
1-Year Change
-46.14%
Global Rank
Country Rank
#3,707 United States
Category
ChartMarket Cap Chart
Since September 30, 2024, Veraxa Biotech AG's market cap has decreased from $315.30M to $178.17M, a decrease of -43.49%. That is a compound annual growth rate of -24.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 178.17M | -47.20% |
| Dec 31, 2025 | 337.44M | 6.49% |
| Dec 30, 2024 | 316.88M | 0.50% |
| Sep 30, 2024 | 315.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MediWound | 160.35M |
| Satellos Bioscience | 159.40M |
| Nkarta | 159.01M |
| NovaBridge Biosciences | 158.92M |
| Protara Therapeutics | 156.60M |
| Korro Bio | 155.80M |
| Jyong Biotech | 155.15M |
| Minerva Neurosciences | 153.75M |